Drug Safety Symposium 2024 unfolded as a beacon of innovation, collaboration, and excellence in the realm of Pharmacovigilance, Regulatory Affairs, and Quality Assurance. Held on February 14th -15th, 2024 at the Holiday Inn & Suites, the symposium marked a milestone in advancing drug safety standards and fostering transformative dialogue within the pharma industry. The two-day event, meticulously curated by Eminence Group Ventures, brought together industry leaders, experts, and enthusiasts to explore groundbreaking insights, share best practices, and address the evolving challenges in drug safety and pharmacovigilance.
Diverse Perspectives, Uniting Voices
In-depth sessions from Regulatory leaders from UAE, Kuwait, Oman, and Jordan along with industry experts from UAE, Saudi Arabia, India, Europe, USA, each session was a testament to the power of diverse perspectives and uniting voices in shaping the future of drug safety.
Unraveling Insights and Solutions
Distinguished speakers, including Dr. Katya Nabeel Ailabouni, Dr. Ahmed Hegazy, Dr. Shahinaz Badr, Dr. Raghda Mohamed, Dr. Hamza Garashi, Dr. Esraa A. Zoubi, Dr. Omar Aimer, Dr. Eman Gomaa, Dr. Gozde Olkay, Dr. Ranjit Barshikar, Dr. Upendra Quenim, Dr. Ali Ridha, Dr. Ahmed Izhar Mansuri, Dr. Syed Zafferudin, Mr. Jose Alaiya Ortiz and many more, graced the symposium with their expertise and insights. Their thought- provoking presentations delved into pivotal topics such as pharmacovigilance regulations, patient safety, data integrity, and quality management, illuminating pathways for enhanced drug safety and regulatory excellence.
Interactive Engagement and Enriching Experiences
Attendees actively participated in interactive sessions, quizzes, and engaging activities, enriching their understanding of drug safety practices and regulations. From pop quizzes to the innovative LEGO Serious Play and insightful group activities, each moment was crafted to inspire learning, collaboration, and fun.
Celebrating Exceptional Achievements
As the symposium drew to a close, it was a moment of celebration as attendees reflected on the exceptional achievements and insights garnered throughout the event. From vibrant discussions to networking opportunities, the symposium left an indelible mark, igniting passion and commitment to uphold the highest standards in drug safety. The symposium catalyzed ongoing dialogue, exploration, and transformation, paving the way for a brighter, safer future in the pharmaceutical industry.
